Equities

AroCell AB (publ)

AroCell AB (publ)

Actions
  • Price (SEK)0.716
  • Today's Change0.016 / 2.29%
  • Shares traded556.47k
  • 1 Year change-13.53%
  • Beta1.6712
Data delayed at least 15 minutes, as of Jan 26 2023 17:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

AroCell publ AB is a Sweden-based diagnostic Company engaged in the development of markers for determination of cell growth (TK 210) and apoptosis. The Company's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood cancer. The test is based on a patented technology, which have already been evaluated in an early product prototype ELISA method. Apart from that, the Company develops a marker for solid tumor cancer disease. The AroCell cooperates with partners within development, production and sales.

  • Revenue in SEK (TTM)30.41m
  • Net income in SEK-62.15m
  • Incorporated2000
  • Employees--
  • Location
    AroCell AB (publ)Karlsbodavagen 39BROMMA 168 67SwedenSWE
  • Phone+46 18503020
  • Websitehttps://arocell.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Klaria Pharma Holding AB (publ)0.00-89.99m126.38m----1.71-----1.54-1.540.000.6230.00-------85.46-29.15-132.95-33.67-------2,713.74---16.670.0211-------4.07------
PCI Biotech Holding ASA4.94m-76.43m130.12m17.00--1.97--26.31-1.97-1.970.12731.700.0416--0.5862279,529.40-64.25-33.17-72.79-36.55-----1,545.58-762.80----0.0221---14.86-9.75-22.36------
Isofol Medical AB (publ)15.65m-195.59m131.15m15.00--0.7135--8.38-4.22-4.220.1241.140.0441--1.171,043,000.00-55.10-61.04-69.25-74.66-1,086.11---1,250.18-1,186.01----0.0023---39.63---5.96------
Toleranzia AB0.00-8.14m132.38m----1.09-----0.0673-0.06730.001.100.00-------6.19-12.63-6.43-13.30------------0.0069-------27.68--55.48--
2cureX AB8.00k-28.86m139.59m----2.75--17,448.89-1.76-1.760.00052.880.0001--0.0011---42.42-23.18-44.73-27.65-176,600.00-88,517.02-360,787.50-94,872.34----0.00-------158.70---37.81--
Coegin Pharma AB0.00-35.59m146.00m----5.98-----0.0516-0.05160.000.02640.00-------142.04---158.13-------------1,546.570.00------41.29------
Xintela AB0.00-78.22m150.71m-----------0.5315-0.53150.00-0.00850.00-------302.11-119.65-559.20-180.99-------12,122.000.3763-17.76---------19.76--27.36--
Aqua Bio Technology ASA1.68m-23.62m155.11m2.00--19.61--92.49-1.13-1.130.08040.36770.06440.66061.50---90.75-73.71-152.91-100.31-117.42-41.86-1,408.30-2,046.060.3127-12.490.4955--250.98---33.32--56.78--
Peptonic Medical AB36.14m-73.58m157.78m----0.9062--4.37-0.2277-0.22770.10750.14350.41881.043.39---85.26-38.78-113.84-45.5560.91---203.61-223.580.5254-38.840.2223---10.10---115.39---16.66--
AroCell AB (publ)30.41m-62.15m161.25m----0.6746--5.30-0.3854-0.38540.1641.040.12244.768.63---25.27-32.88-26.58-35.44-15.37-37.34-206.39-966.137.41-20,923.000.00--14,180.95194.00-107.99---47.95--
StenoCare A/S2.47m-26.78m161.52m----3.92--65.36-1.53-1.530.14112.350.0389--3.01---42.17---44.49-------1,083.68--2.77-26.150.2065--854.55---8.03------
New Nordic Healthbrands AB496.85m-3.79m163.55m37.00--1.41--0.3292-0.6121-0.612180.2018.741.954.133.96---1.4913.05-3.0725.3611.7917.56-0.76325.290.9924-1.860.308238.8714.3910.9819.9217.3535.3325.59
Combigene AB105.40m63.23m177.02m--2.801.082.691.683.193.195.328.290.764--9.52--45.84-19.2947.74-24.55----60.00-55.8524.54--0.00------171.35------
Annexin Pharmaceuticals AB (publ)0.00-46.51m197.76m4.00--5.98-----0.4186-0.41860.000.21410.00-------178.18-118.13-224.56-143.44-----------23.980.00-------17.86------
Saniona AB14.86m-333.55m199.63m25.00--2.19--13.44-5.35-5.350.23821.460.0409--5.04303,224.50-91.79-54.80-101.62-66.36-1,376.92-447.87-2,244.89-634.11---27.610.473--27.81-32.53-459.58--12.71--
Targovax ASA0.00-111.32m201.22m20.00--0.5396-----0.7255-0.72550.001.900.00----0.00-22.52-23.02-24.21-24.83-------21,183.60---74.710.1444---100.00--9.39------
Data as of Jan 26 2023. Currency figures normalised to AroCell AB (publ)'s reporting currency: Swedish Krona SEK

Institutional shareholders

0.35%Per cent of shares held by top holders
HolderShares% Held
Arvernus Capital AGas of 31 Mar 2022800.00k0.35%
Data from 31 Mar 2022 - 31 Mar 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.